|
1
|
Dang CV: c-Myc target genes involved in
cell growth, apoptosis, and metabolism. Mol Cell Biol. 19:1–11.
1999. View Article : Google Scholar
|
|
2
|
Wu Y and Li Z: Oncogene c-myc and
malignant tumor. Clin Res. 25:1698–1700. 2008.
|
|
3
|
Kotake T, Saiki S, Kinouchi T, Shiku H and
Nakayama E: Detection of the c-myc gene product in urinary bladder
cancer. Jpn J Cancer Res. 81:1198–1201. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Masters JR, Vesey SG, Munn CF, Evan GI and
Watson JV: c-myc oncoprotein levels in bladder cancer. Urol Res.
16:341–344. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Levens D: Disentangling the MYC web. Proc
Natl Acad Sci USA. 99:5757–5759. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li LH, Nerlov C, Prendergast G, Macgregor
D and Ziff EB: c-Myc represses transcription in vivo by a novel
mechanism dependent on the initiator element and Myc box II. EMBO
J. 13:4070–4079. 1994.PubMed/NCBI
|
|
7
|
Peukert K, Staller P, Schneider A,
Carmichael G, Hänel F and Eilers M: An alternative pathway for gene
regulation by Myc. EMBO J. 16:5672–5686. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Phan RT, Saito M, Basso K, Niu H and
Dalla-Favera R: BCL6 interacts with the transcription factor Miz-1
to suppress the cyclin-dependent kinase inhibitor p21 and cell
cycle arrest in germinal center B cells. Nat Immunol. 6:1054–1060.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Basu S, Liu Q, Qiu Y and Dong F: gfi-1
represses CDKN2B encoding p15INK4B through interaction
with Miz-1. Proc Natl Acad Sci USA. 106:1433–1438. 2009. View Article : Google Scholar
|
|
10
|
Lu J, Chen M, Ren XR, Wang J, Lyerly HK,
Barak L and Chen W: Regulation of Hedgehog signaling by
Myc-interacting zinc finger protein 1, Miz1. PLoS One.
8:e633532013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Inoue S, Hao Z, Elia AJ, Cescon D, Zhou L,
Silvester J, Snow B, Harris IS, Sasaki M, Li WY, et al:
Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by
preventing c-Myc/Miz1-mediated down-regulation of p21 and p15.
genes Dev. 27:1101–1114. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
van Riggelen J, Müller J, Otto T, Beuger
V, Yetil A, Choi PS, Kosan C, Möröy T, Felsher DW and Eilers M: The
interaction between Myc and Miz1 is required to antagonize
TGFbeta-dependent autocrine signaling during lymphoma formation and
maintenance. genes Dev. 24:1281–1294. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gebhardt A, Kosan C, Herkert B, Möröy T,
Lutz W, Eilers M and Elsässer HP: Miz1 is required for hair
follicle structure and hair morphogenesis. J Cell Sci.
120:2586–2593. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Seoane J, Le HV and Massagué J: Myc
suppression of the p21Cip1 Cdk inhibitor influences the
outcome of the p53 response to DNA damage. Nature. 419:729–734.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu S, Cetinkaya C, Munoz-Alonso MJ, von
der Lehr N, Bahram F, Beuger V, Eilers M, Leon J and Larsson LG:
Myc represses differentiation-induced p21CIP1 expression via
Miz-1-dependent interaction with the p21 core promoter. Oncogene.
22:351–360. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Adhikary S, Peukert K, Karsunky H, Beuger
V, Lutz W, Elsässer HP, Möröy T and Eilers M: Miz1 is required for
early embryonic development during gastrulation. Mol Cell Biol.
23:7648–7657. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gebhardt A, Frye M, Herold S, Benitah SA,
Braun K, Samans B, Watt FM, Elsässer HP and Eilers M: Myc regulates
keratinocyte adhesion and differentiation via complex formation
with Miz1. J Cell Biol. 172:139–149. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Saba I, Kosan C, Vassen L and Möröy T:
IL-7R-dependent survival and differentiation of early T-lineage
progenitors is regulated by the BTB/POZ domain transcription factor
Miz-1. Blood. 117:3370–3381. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hönnemann J, Sanz-Moreno A, Wolf E, Eilers
M and Elsässer HP: Miz1 is a critical repressor of cdkn1a during
skin tumorigenesis. PLoS One. 7:e348852012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu J, Yan J, Jiang S, Wen J, Chen L, Zhao
Y and Lin A: Site-specific ubiquitination is required for relieving
the transcription factor Miz1-mediated suppression on TNF-α-induced
JNK activation and inflammation. Proc Natl Acad Sci USA.
109:191–196. 2012. View Article : Google Scholar
|
|
21
|
Li Z and Li B: Correlation of gene
polymorphism of p21 and p27 with tumor. Int J gene. 29:317–320.
2006.
|
|
22
|
Krauss Gerhard; Sun C, Liu JS, et al:
Biochemistry of Signal Transduction and Regulation. Chemical
Industry Press; pp. 338–377. 2005
|
|
23
|
Palazzo JP, Mercer WE, Kovatich AJ and
McHugh M: Immunohistochemical localization of
p21WAF1/CIP1 in normal, hyperplastic, and neoplastic
uterine tissues. Hum Pathol. 28:60–66. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang J, Lv H, Jing L and Qin J:
Expression of p21cip1/WAF, p53 and the infection of
HPV-16 in the esophageal cancer. Shi Yong Ai Zheng Za Zhi She.
19:488–490. 2004.In Chinese.
|
|
25
|
Tanaka Y, Fujii T, Yamana H, Kato S,
Morimatsu M and Shirouzu K: Experimental gene therapy using
p21Waf1 gene for esophageal squamous cell carcinoma by
gene gun technology. Int J Mol Med. 14:545–551. 2004.PubMed/NCBI
|
|
26
|
Liu J, Hu Y, Hu W, Xie X, Ela Bella A, Fu
J and Rao D: Expression and prognostic relevance of
p21WAF1 in stage III esophageal squamous cell carcinoma.
Dis Esophagus. 25:67–71. 2012. View Article : Google Scholar
|
|
27
|
Zhang H, Liu Y and Hu M: Expression and
significance of p53, p21, p16, cyclin D and CDK, in esophageal
squamous cell carcinoma. Immunological J. 4:312–315. 2003.
|
|
28
|
Möröy T, Saba I and Kosan C: The role of
the transcription factor Miz-1 in lymphocyte development and
lymphomagenesis-binding Myc makes the difference. Semin Immunol.
23:379–387. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Montgomery EA: Oesophageal cancer. (World
Cancer Report 2014). Stewart BW and Wild CP: International Agency
for Research on Cancer; Lyon: pp. 374–382. 2014
|
|
30
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Gobal cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen W, Zheng R, Zhang S, Zhao P, Zeng H
and Zou X: Report of cancer incidence and mortality in China, 2010.
Ann Transl Med. 2:612014.PubMed/NCBI
|
|
32
|
Deshpande A, Sicinski P and Hinds PW:
Cyclins and cdks in development and cancer: A perspective.
Oncogene. 24:2909–2915. 2005. View Article : Google Scholar : PubMed/NCBI
|
